Oppenheimer Upgrades Agios Pharma On Expectations For First Drug Launch
January 17, 2017 at 14:42 PM EST
Oppenheimer has upgraded Agios Pharmaceuticals Inc (NASDAQ: AGIO) shares to Outperform from Perform on higher expectations for its first ...